Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 45.55 is 69% below its 1-year average of 147.35, near the low end of its 1-year range (41.10–268.71).
As of 2026-10-06T12:25:24.630Z.
Calculation as of: 2026-10-06T12:25:24.630Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5634534592ddc0dff26210766547620705b04d4b3456080b551355077da80429
PE Ratio (45.55) = Close Price ($8.50) / Diluted TTM EPS ($0.19)
PE RATIO
45.55
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.67
median of 125 covered companies
CURRENT VS SECTOR MEDIAN
+77.44%
vs the sector median at left
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.76B | 45.55 | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | N/A | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | N/A | 23.72 | 50.63 | 57.39 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 45.03 | 79.20 | 49.35 | 42.48 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | N/A | 3.28 | 3.28 | 3.28 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 15.68 | 29.99 | 47.18 | 47.18 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | N/A | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 37.72 | 35.65 | 35.65 | 327.33 |
| Absci Corporation (ABSI)vs › | $1.95B | N/A | N/A | N/A | N/A |
At 45.5, P/E is at an extreme level, where the multiple carries little signal — higher than 11% of readings in its 1-year history.
1-year low
41.1
median
172.9
1-year high
268.7
Trailing P/E
45.5
Forward P/E
46.8
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$8.50
Forward EPS (Est.)
$0.18
Forward P/E
46.82
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 45.55 |
| 2026-10-02 | 42.55 |
| 2026-10-01 | 41.48 |
| 2026-09-30 | 43.73 |
| 2026-09-29 | 42.39 |
| 2026-09-28 | 42.50 |
| 2026-09-25 | 44.00 |
| 2026-09-24 | 41.10 |
| 2026-09-23 | 42.12 |
| 2026-09-22 | 42.82 |
| 2026-09-21 | 44.64 |
| 2026-09-18 | 44.75 |
| 2026-09-17 | 46.62 |
| 2026-09-16 | 46.68 |
| 2026-09-15 | 55.57 |
| 2026-09-14 | 69.35 |
| 2026-09-11 | 67.58 |
| 2026-09-10 | 68.38 |
| 2026-09-09 | 69.83 |
| 2026-09-08 | 72.13 |
| 2026-09-04 | 72.56 |
| 2026-09-03 | 72.62 |
| 2026-09-02 | 72.83 |
| 2026-09-01 | 72.83 |
| 2026-08-31 | 71.81 |
| 2026-08-28 | 72.99 |
| 2026-08-27 | 72.67 |
| 2026-08-26 | 74.49 |
| 2026-08-25 | 72.83 |
| 2026-08-24 | 71.97 |
| 2026-08-21 | 70.53 |
| 2026-08-20 | 69.29 |
| 2026-08-19 | 68.49 |
| 2026-08-18 | 70.90 |
| 2026-08-17 | 72.13 |
| 2026-08-14 | 74.81 |
| 2026-08-13 | 72.13 |
| 2026-08-12 | 72.45 |
| 2026-08-11 | 70.74 |
| 2026-08-10 | 73.85 |
| 2026-08-07 | 77.01 |
| 2026-08-06 | 71.70 |
| 2026-08-05 | 73.31 |
| 2026-08-04 | 72.45 |
| 2026-08-03 | 78.03 |
| 2026-07-31 | 79.58 |
| 2026-07-30 | 203.61 |
| 2026-07-29 | 200.11 |
| 2026-07-28 | 201.64 |
| 2026-07-27 | 204.27 |
| 2026-07-24 | 212.58 |
| 2026-07-23 | 218.82 |
| 2026-07-22 | 227.24 |
| 2026-07-21 | 235.23 |
| 2026-07-20 | 230.85 |
| 2026-07-17 | 225.38 |
| 2026-07-16 | 219.15 |
| 2026-07-15 | 228.99 |
| 2026-07-14 | 231.95 |
| 2026-07-13 | 222.98 |
| 2026-07-10 | 216.96 |
| 2026-07-09 | 230.09 |
| 2026-07-08 | 219.15 |
| 2026-07-07 | 263.13 |
| 2026-07-06 | 268.71 |
| 2026-07-02 | 260.39 |
| 2026-07-01 | 262.69 |
| 2026-06-30 | 260.50 |
| 2026-06-29 | 254.49 |
| 2026-06-26 | 253.72 |
| 2026-06-25 | 248.47 |
| 2026-06-24 | 237.31 |
| 2026-06-23 | 236.98 |
| 2026-06-22 | 232.93 |
| 2026-06-18 | 239.17 |
| 2026-06-17 | 234.35 |
| 2026-06-16 | 225.38 |
| 2026-06-15 | 216.41 |
| 2026-06-12 | 216.08 |
| 2026-06-11 | 221.44 |
| 2026-06-10 | 224.95 |
| 2026-06-09 | 210.07 |
| 2026-06-08 | 167.94 |
| 2026-06-05 | 168.16 |
| 2026-06-04 | 164.88 |
| 2026-06-03 | 155.91 |
| 2026-06-02 | 149.23 |
| 2026-06-01 | 145.51 |
| 2026-05-29 | 167.61 |
| 2026-05-28 | 173.63 |
| 2026-05-27 | 174.29 |
| 2026-05-26 | 175.38 |
| 2026-05-22 | 178.88 |
| 2026-05-21 | 179.10 |
| 2026-05-20 | 182.28 |
| 2026-05-19 | 178.99 |
| 2026-05-18 | 178.12 |
| 2026-05-15 | 172.10 |
| 2026-05-14 | 181.18 |
| 2026-05-13 | 199.89 |
| 2026-05-12 | 201.09 |
| 2026-05-11 | 187.75 |
| 2026-05-08 | 196.17 |
| 2026-05-07 | 199.67 |
| 2026-05-06 | 198.47 |
| 2026-05-05 | 200.22 |
| 2026-05-04 | 210.72 |
| 2026-05-01 | 221.66 |